Zentalis Pharmaceuticals
ZNTL
#9381
Rank
โ‚น12.38 B
Marketcap
โ‚น126.02
Share price
0.00%
Change (1 day)
4.97%
Change (1 year)

EPS for Zentalis Pharmaceuticals (ZNTL)

EPS in 2026 (TTM): -โ‚น167.33

According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น169.57. In 2021 the company made an earnings per share (EPS) of -โ‚น350.25 a decrease over its 2020 EPS that were of -โ‚น295.63.

EPS history for Zentalis Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น167.33
2021-โ‚น350.2518.48%
2020-โ‚น295.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น17.61-89.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.03-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA